Jim Cramer - Mad MoneySurface OncologySURFRISKYJan 15, 2021

A fabulous spec because it's in genomics and oncology, which is a good business to be in.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$12.30

Stock price when the opinion was issued

$1.07

As of Sep 07, 2023. Market Open.

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Most Recent Experts

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Josh Brown, CEO, Ritholtz Wealth Management

Ritholtz Wealth Management

Amy Raskin, CIO, Chevy Chase Trust

Chevy Chase Trust

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Jim Cramer - Mad MoneySurface OncologySURFRISKYJan 15, 2021

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals